Analysis of the Initiating Events in HIV-1 Particle Assembly and Genome Packaging

HIV-1 Gag drives a number of events during the genesis of virions and is the only viral protein required for the assembly of virus-like particles in vitro and in cells. Although a reasonable understanding of the processes that accompany the later stages of HIV-1 assembly has accrued, events that occur at the initiation of assembly are less well defined. In this regard, important uncertainties include where in the cell Gag first multimerizes and interacts with the viral RNA, and whether Gag-RNA interaction requires or induces Gag multimerization in a living cell. To address these questions, we developed assays in which protein crosslinking and RNA/protein co-immunoprecipitation were coupled with membrane flotation analyses in transfected or infected cells. We found that interaction between Gag and viral RNA occurred in the cytoplasm and was independent of the ability of Gag to localize to the plasma membrane. However, Gag:RNA binding was stabilized by the C-terminal domain (CTD) of capsid (CA), which participates in Gag-Gag interactions. We also found that Gag was present as monomers and low-order multimers (e.g. dimers) but did not form higher-order multimers in the cytoplasm. Rather, high-order multimers formed only at the plasma membrane and required the presence of a membrane-binding signal, but not a Gag domain (the CA-CTD) that is essential for complete particle assembly. Finally, sequential RNA-immunoprecipitation assays indicated that at least a fraction of Gag molecules can form multimers on viral genomes in the cytoplasm. Taken together, our results suggest that HIV-1 particle assembly is initiated by the interaction between Gag and viral RNA in the cytoplasm and that this initial Gag-RNA encounter involves Gag monomers or low order multimers. These interactions per se do not induce or require high-order Gag multimerization in the cytoplasm. Instead, membrane interactions are necessary for higher order Gag multimerization and subsequent particle assembly in cells.

[1]  Chris M. Brown,et al.  Live cell visualization of the interactions between HIV-1 Gag and the cellular RNA-binding protein Staufen1 , 2010, Retrovirology.

[2]  M. Bewley,et al.  Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyopherins and viral RNA , 2010, Proceedings of the National Academy of Sciences.

[3]  E. Poeschla,et al.  Live-Cell Coimaging of the Genomic RNAs and Gag Proteins of Two Lentiviruses , 2010, Journal of Virology.

[4]  P. Bieniasz,et al.  Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles , 2009, Proceedings of the National Academy of Sciences.

[5]  M. G. Mateu The capsid protein of human immunodeficiency virus: intersubunit interactions during virus assembly , 2009, The FEBS journal.

[6]  Jianbo Chen,et al.  Probing the HIV-1 Genomic RNA Trafficking Pathway and Dimerization by Genetic Recombination and Single Virion Analyses , 2009, PLoS pathogens.

[7]  A. Hoppe,et al.  Quantitative Fluorescence Resonance Energy Transfer Microscopy Analysis of the Human Immunodeficiency Virus Type 1 Gag-Gag Interaction: Relative Contributions of the CA and NC Domains and Membrane Binding , 2009, Journal of Virology.

[8]  L. Parent,et al.  Genetic Evidence for a Connection between Rous Sarcoma Virus Gag Nuclear Trafficking and Genomic RNA Packaging , 2009, Journal of Virology.

[9]  Jeremy G. Carlton,et al.  The ESCRT machinery: new functions in viral and cellular biology. , 2009, Biochemical Society transactions.

[10]  Sanford M. Simon,et al.  Imaging the biogenesis of individual HIV-1 virions in live cells , 2008, Nature.

[11]  Mark Yeager,et al.  The structural biology of HIV assembly. , 2008, Current opinion in structural biology.

[12]  P. Spearman,et al.  Myristoylation Is Required for Human Immunodeficiency Virus Type 1 Gag-Gag Multimerization in Mammalian Cells , 2007, Journal of Virology.

[13]  R. Gordon,et al.  Sequence of Human Immunodeficiency Virus Type 1 (HIV-1) Gag Localization and Oligomerization Monitored with Live Confocal Imaging of a Replication-Competent, Fluorescently Tagged HIV-1 , 2007, Journal of Virology.

[14]  Simon C Watkins,et al.  Distinct Intracellular Trafficking of Equine Infectious Anemia Virus and Human Immunodeficiency Virus Type 1 Gag during Viral Assembly and Budding Revealed by Bimolecular Fluorescence Complementation Assays , 2007, Journal of Virology.

[15]  Alexandre Orthwein,et al.  Productive Human Immunodeficiency Virus Type 1 Assembly Takes Place at the Plasma Membrane , 2007, Journal of Virology.

[16]  S. Biswal,et al.  Selective and Nonselective Packaging of Cellular RNAs in Retrovirus Particles , 2007, Journal of Virology.

[17]  H. Kräusslich,et al.  HIV-1 Buds Predominantly at the Plasma Membrane of Primary Human Macrophages , 2007, PLoS pathogens.

[18]  M. Summers,et al.  Point mutations in the HIV-1 matrix protein turn off the myristyl switch. , 2007, Journal of molecular biology.

[19]  P. Clark,et al.  Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. , 2007, Journal of molecular biology.

[20]  Marc C. Johnson,et al.  Plasma Membrane Is the Site of Productive HIV-1 Particle Assembly , 2006, PLoS biology.

[21]  T. Hope,et al.  Mobility of Human Immunodeficiency Virus Type 1 Pr55Gag in Living Cells , 2006, Journal of Virology.

[22]  M. Summers,et al.  Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Bieniasz,et al.  Late budding domains and host proteins in enveloped virus release. , 2006, Virology.

[24]  E. Freed,et al.  Association of Human Immunodeficiency Virus Type 1 Gag with Membrane Does Not Require Highly Basic Sequences in the Nucleocapsid: Use of a Novel Gag Multimerization Assay , 2005, Journal of Virology.

[25]  M. Summers,et al.  How retroviruses select their genomes , 2005, Nature Reviews Microbiology.

[26]  M. Wainberg,et al.  Mutation of the SP1 Sequence Impairs both Multimerization and Membrane-Binding Activities of Human Immunodeficiency Virus Type 1 Gag , 2005, Journal of Virology.

[27]  D. Pérez-Caballero,et al.  APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles , 2004, Journal of Virology.

[28]  K. Nagashima,et al.  Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Wainberg,et al.  In Vitro Identification and Characterization of an Early Complex Linking HIV-1 Genomic RNA Recognition and Pr55Gag Multimerization* , 2004, Journal of Biological Chemistry.

[30]  D. Pérez-Caballero,et al.  Human Immunodeficiency Virus Type 1 Matrix Inhibits and Confers Cooperativity on Gag Precursor-Membrane Interactions , 2004, Journal of Virology.

[31]  Marc C. Johnson,et al.  The stoichiometry of Gag protein in HIV-1 , 2004, Nature Structural &Molecular Biology.

[32]  Roland Marquet,et al.  Dimerization of retroviral RNA genomes: an inseparable pair , 2004, Nature Reviews Microbiology.

[33]  Aaron Derdowski,et al.  A Novel Fluorescence Resonance Energy Transfer Assay Demonstrates that the Human Immunodeficiency Virus Type 1 Pr55Gag I Domain Mediates Gag-Gag Interactions , 2004, Journal of Virology.

[34]  John W. Mellors,et al.  New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma , 2003, Journal of Clinical Microbiology.

[35]  W. Webb,et al.  Direct measurement of Gag–Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopy , 2003, The Journal of cell biology.

[36]  Wesley I. Sundquist,et al.  Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein , 2003, Journal of Virology.

[37]  M. Wainberg,et al.  A Structurally Disordered Region at the C Terminus of Capsid Plays Essential Roles in Multimerization and Membrane Binding of the Gag Protein of Human Immunodeficiency Virus Type 1 , 2003, Journal of Virology.

[38]  M. Wainberg,et al.  Characterization of a Putative α-Helix across the Capsid-SP1 Boundary That Is Critical for the Multimerization of Human Immunodeficiency Virus Type 1 Gag , 2002, Journal of Virology.

[39]  M. Wainberg,et al.  Role of RNA in Facilitating Gag/Gag-Pol Interaction , 2002, Journal of Virology.

[40]  Y. Durocher,et al.  High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. , 2002, Nucleic acids research.

[41]  A. Rein,et al.  RNA is a structural element in retrovirus particles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Wesley I. Sundquist,et al.  Image reconstructions of helical assemblies of the HIV-1 CA protein , 2022 .

[43]  B. Strack,et al.  Efficient Particle Production by Minimal Gag Constructs Which Retain the Carboxy-Terminal Domain of Human Immunodeficiency Virus Type 1 Capsid-p2 and a Late Assembly Domain , 2000, Journal of Virology.

[44]  E. Freed,et al.  Relationship between Human Immunodeficiency Virus Type 1 Gag Multimerization and Membrane Binding , 2000, Journal of Virology.

[45]  J. Luban,et al.  Basic Residues in Human Immunodeficiency Virus Type 1 Nucleocapsid Promote Virion Assembly via Interaction with RNA , 2000, Journal of Virology.

[46]  A. Simoes-Barbosa,et al.  Solubilization of delipidated macrophage membrane proteins for analysis by two‐dimensional electrophoresis , 2000, Electrophoresis.

[47]  I. Jones,et al.  Roles of Matrix, p2, and N-Terminal Myristoylation in Human Immunodeficiency Virus Type 1 Gag Assembly , 2000, Journal of Virology.

[48]  J. Luban,et al.  Human Immunodeficiency Virus Type 1 Gag Polyprotein Multimerization Requires the Nucleocapsid Domain and RNA and Is Promoted by the Capsid-Dimer Interface and the Basic Region of Matrix Protein , 1999, Journal of Virology.

[49]  A. Rein,et al.  In Vitro Assembly Properties of Human Immunodeficiency Virus Type 1 Gag Protein Lacking the p6 Domain , 1999, Journal of Virology.

[50]  A. Rein,et al.  Importance of Basic Residues in the Nucleocapsid Sequence for Retrovirus Gag Assembly and Complementation Rescue , 1998, Journal of Virology.

[51]  Chin-Tien Wang,et al.  Analysis of Minimal Human Immunodeficiency Virus Type 1 gag Coding Sequences Capable of Virus-Like Particle Assembly and Release , 1998, Journal of Virology.

[52]  H. Gelderblom,et al.  Efficient HIV‐1 replication can occur in the absence of the viral matrix protein , 1998, The EMBO journal.

[53]  W. Sundquist,et al.  Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. , 1997, Science.

[54]  H. Kräusslich,et al.  In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. , 1997, European journal of biochemistry.

[55]  L. Ratner,et al.  Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism , 1997, Journal of virology.

[56]  W. Sundquist,et al.  Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  V. Vogt,et al.  Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1 , 1995, Journal of virology.

[58]  C. Sassetti,et al.  RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1 , 1995, Journal of virology.

[59]  J. Luban,et al.  Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity , 1995, Journal of virology.

[60]  S. Höglund,et al.  Functional domains of the capsid protein of human immunodeficiency virus type 1 , 1994, Journal of virology.

[61]  M. Linial,et al.  Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal , 1994, Journal of virology.

[62]  J. Luban,et al.  Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA , 1994, Journal of virology.

[63]  M. Resh,et al.  Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids , 1994, Journal of virology.

[64]  E. Barklis,et al.  Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant , 1993, Journal of virology.

[65]  A. Lever,et al.  The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure , 1992, Journal of virology.

[66]  J. Sodroski,et al.  Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions , 1989, Journal of virology.

[67]  J. Sodroski,et al.  Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[68]  S. Tenenbaum,et al.  Advances in RIP-chip analysis : RNA-binding protein immunoprecipitation-microarray profiling. , 2008, Methods in molecular biology.

[69]  Kevin Struhl,et al.  Quantitative sequential chromatin immunoprecipitation, a method for analyzing co-occupancy of proteins at genomic regions in vivo. , 2004, Nucleic acids research.

[70]  E. Freed,et al.  Retrovirus budding. , 2004, Virus research.

[71]  W. Sundquist,et al.  Assembly and analysis of conical models for the HIV-1 core. , 1999, Science.

[72]  L. Ratner,et al.  Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.